CS&Z has been identified as a candidate for such an approach, demonstrating for the first time its ability to induce apoptosis in colorectal cancer cells via RPL5-mediated inhibition of the oncogene c-Myc. This evidence concerns the gene RPL5 and colorectal cancer.